tiprankstipranks
Oric Pharmaceuticals (ORIC)
NASDAQ:ORIC

Oric Pharmaceuticals (ORIC) Financial Statements

272 Followers

Oric Pharmaceuticals Financial Overview

Oric Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.81; its P/E ratio is -4.15; Oric Pharmaceuticals is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -28.99M$ -31.43M$ -25.48M$ -22.94M$ -23.95M
EBITDA$ -28.73M$ -31.16M$ -27.14M$ -23.95M$ -24.55M
Net Income Common Stockholders$ -25.01M$ -28.33M$ -25.48M$ -22.94M$ -23.95M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 316.78M$ 208.19M$ 227.30M$ 264.16M$ 189.63M
Total Assets$ 350.79M$ 252.01M$ 274.33M$ 291.82M$ 226.65M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -316.78M$ -208.19M$ -227.30M$ -264.16M$ -189.63M
Total Liabilities$ 22.14M$ 27.92M$ 26.92M$ 23.02M$ 23.84M
Stockholders Equity$ 328.68M$ 224.09M$ 247.41M$ 268.82M$ 202.79M
Cash Flow-
Free Cash Flow$ -30.40M$ -24.33M$ -19.72M$ -21.55M$ -20.94M
Operating Cash Flow$ -30.19M$ -24.27M$ -19.64M$ -21.14M$ -20.63M
Investing Cash Flow$ -61.87M$ 20.96M$ -57.83M$ -19.31M$ 12.78M
Financing Cash Flow$ 125.03M$ 453.00K$ 31.00K$ 85.17M-
Currency in USD

Oric Pharmaceuticals Earnings and Revenue History

Oric Pharmaceuticals Debt to Assets

Oric Pharmaceuticals Cash Flow

Oric Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis